Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H33ClO13 |
Molecular Weight | 613.007 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)C=C1
InChI
InChIKey=KFRDLOWUHLQEAX-GCGVPRHFSA-N
InChI=1S/C28H33ClO13/c1-2-38-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)29)28-24(21(34)23(35)27(11-30,42-28)12-39-28)41-26-20(33)18(31)19(32)22(40-26)25(36)37/h3-8,10,18-24,26,30-35H,2,9,11-12H2,1H3,(H,36,37)/t18-,19-,20+,21-,22-,23-,24+,26-,27-,28-/m0/s1
Molecular Formula | C28H33ClO13 |
Molecular Weight | 613.007 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:36:12 GMT 2023
by
admin
on
Sat Dec 16 14:36:12 GMT 2023
|
Record UNII |
3G8R6SUZ3C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
118753360
Created by
admin on Sat Dec 16 14:36:12 GMT 2023 , Edited by admin on Sat Dec 16 14:36:12 GMT 2023
|
PRIMARY | |||
|
1500090-84-5
Created by
admin on Sat Dec 16 14:36:12 GMT 2023 , Edited by admin on Sat Dec 16 14:36:12 GMT 2023
|
PRIMARY | |||
|
3G8R6SUZ3C
Created by
admin on Sat Dec 16 14:36:12 GMT 2023 , Edited by admin on Sat Dec 16 14:36:12 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
(PLASMA CIRCULATION) 12.2%, (URINE) 5.7%, (FECES) N.D.%, AFTER ADMINISTRATION OF A SINGLE 25-MG (100 MICROCURIE) ORAL DOSE OF (14C)-ERTUGLIFLOZIN (N=6, ALL MALE)
IN-VIVO
PLASMA; URINE
|